elaine 1: las vs fulv in la er /her2- mbc esr1m disease progression on ai and cdk4/6i inhibitors
Published 1 year ago • 120 plays • Length 5:47Download video MP4
Download video MP3
Similar videos
-
2:06
elaine 1: esr1 mutations in ctdna from er /her2- mbc treated with lasofoxifene or fulvestrant
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
2:35
lasofoxifene shows promise for women with esr1-mutated mbc
-
4:34
lasofoxifene vs fulvestrant for locally advanced/metastatic er /her2- breast cancer: elaine trial
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
5:07
what is the role of cdk4/6 inhibitors in early breast cancer?
-
2:35
lri's and cci's with the #lensar laser system
-
0:38
#lensar - measurement guided laser (investigational device)
-
1:22
impact of ai on patient decision making in breast cancer
-
1:32
human mcp-1 / ccl2 elisa kit
-
3:08
the use of ai and augmented reality in breast cancer surgery
-
6:43
late hematological malignancies of systemic anticancer therapies
-
0:46
advancing breast cancer detection with ai-powered mammogram analysis
-
1:26
what is a crystal lens implant and why would a patient want to choose this iol lens implant? | eye
-
0:55
“best patient experience of all femtosecond lasers”
-
1:39
human eln / elastin elisa kit (hufi01225)
-
4:57
#presbyopia foundations of the #lensar laser system